HMM302 - Innovations in Medical Biotechnology
|Year||2015 unit information|
Trimester 1: Waurn Ponds (Geelong)
3 x 1 hour classes per week and 1 x 1 hour seminar per week
You will need to access substantial learning resources and experiences in CloudDeakin (Deakin’s online learning environment). Compliance with the Standards in computing, connectivity and student capability are a condition on your enrolment.
This unit provides a comprehensive overview of the business of medical biotechnology, including innovation management, funding, and the regulatory framework relevant to the industry. It will also explore risk management, and the societal and ethical issues pertinent to medical biotechnology in real-world scenarios.
Assessment task 1: Written report 1 (800 words) 20%
Assessment task 2: Written report 2 (800 words) 20%
Assessment task 3: Written report 3 (800 words) 20%
Assessment task 4: Examination (2 hours) 40%
Crommelin, D. J. A., Sindelar R. D., Meibohm, B. 2008. Pharmaceutical Biotechnology: Fundamentals and Applications, 3rd edn, Informa Healthcare, New York, US
Unit Fee Information
|Student Contribution Rate*||Student Contribution Rate**||Fee rate - Domestic Students||Fee rate - International students|
* Rate for all CSP students, except for those who commenced Education and Nursing units pre 2010
** Rate for CSP students who commenced Education and Nursing units pre 2010
Please note: Unit fees listed do not apply to Deakin Prime students.